Ocular Oncology

Top Story

Jerry A. Shields receives first Brady-Shields Endowed Chair in Ocular Oncology

Jerry A. Shields receives first Brady-Shields Endowed Chair in Ocular Oncology
January 15, 2018

Aura Biosciences closes $30 million in Series C funding

December 21, 2017
Aura Biosciences has completed $30 million in Series C financing, according to a company press release. Lundbeckfonden Ventures and Arix Bioscience led the funding, with…
Meeting NewsVideo

VIDEO: Aura hopes to bring first ocular melanoma treatment to fruition

November 17, 2017
NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Elisabet de los Pinos, PhD, CEO of Aura Biosciences, discusses the work the company is doing to bring its…
Meeting NewsPerspective

Light-activated viral nanoparticle for treatment of choroidal melanoma meets early study endpoints

November 12, 2017
NEW ORLEANS — Choroidal melanoma has a high unmet medical need, according to Carol L. Shields, MD, and results of an early-stage study of a light-activated viral…
More Headlines »
Case Report

Detection of Choriocapillaris Loss in Alport Syndrome With Swept-Source OCT Angiography

Ophthalmic Surgery, Lasers and Imaging Retina, February 2018, Volume 49 Issue 2
A patient previously diagnosed with Alport Syndrome was evaluated using multimodal imaging. Optical coherence…
More »

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 4

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Resource Centers
Hawaiian Eye/Retina Meeting

Hawaiian Eye/Retina Meeting


Uveal melanoma treatment improving but metastasis persists

September 30, 2016
More »